|
|
Blood, 1 February 2005, Vol. 105, No. 3, pp. 1310-1318.
Prepublished online as a Blood First Edition Paper on October 7, 2004; DOI 10.1182/blood-2004-03-0933.
Previous Article | Next Article 
Submitted March 11, 2004
Accepted September 24, 2004
Ephrin B2 expression in Kaposi's sarcoma is induced by human herpes virus type 8: phenotype switch from venous to arterial endothelium
Rizwan Masood, Guangbin Xia, D L Smith, Pierluigi Scalia, Jonathan G Still, Anil Tulpule, and Parkash S Gill*
Department of Pathology, University of Southern California Keck School of Medicine, Los Angeles, CA, USA
Department of Medicine, University of Southern California Keck School of Medicine, Los Angeles, CA, USA
Department of Medicine, University of Southern California Keck School of Medicine, Los Angeles, CA, USA; Department of Pathology, University of Southern California Keck School of Medicine, Los Angeles, CA, USA
* Corresponding author; email: parkashg{at}usc.edu.
Kaposi's sarcoma (KS) is an angio-proliferative tumor derived from endothelial cells in which tumor cells form aberrant vascular structures. Ephrin B2 and EphB4 are artery and vein specific proteins, respectively, with critical roles in vessel maturation. We investigated whether the disorganized KS vasculature was due to unbalanced expression of ephrin B2 and EphB4. Secondly, we wished to determine if HHV-8, the viral agent associated with KS, regulates ephrin B2 and EphB4. An arterial phenotype was observed in KS tissue and cell lines, as shown by abundant expression of ephrin B2 with little or no EphB4. Infection of venous endothelial cells with HHV-8 resulted in a phenotype switch from EphB4 to ephrin B2, similar to that seen with VEGF. The HHV-8 effect on ephrin B2 expression was reproduced with the HHV-8 specific viral G-protein coupled receptor. We also showed that ephrin B2 expression is required for KS cell viability by knock-down with siRNA. KS is the first example of a human tumor with a predominantly arterial phenotype. This predominance can be attributed to expression of HHV-8 proteins and their downstream effects. EphrinB2 is thus an important novel factor in KS biology and a potential target for therapy.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
Related Article in Blood Online:
-
Talk amongst yourselves
- William Wachsman
Blood 2005 105: 913-914.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
J. M. Phillips and J. I. Goodman
Identification of Genes that May Play Critical Roles in Phenobarbital (PB)-Induced Liver Tumorigenesis due to Altered DNA Methylation
Toxicol. Sci.,
July 1, 2008;
104(1):
86 - 99.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. A. Kudo, A. Muto, S. P. Maloney, J. M. Pimiento, S. Bergaya, T. N. Fitzgerald, T. S. Westvik, J. C. Frattini, C. K. Breuer, C. H. Cha, et al.
Venous Identity Is Lost but Arterial Identity Is Not Gained During Vein Graft Adaptation
Arterioscler Thromb Vasc Biol,
July 1, 2007;
27(7):
1562 - 1571.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F.-C. Ye, D. J. Blackbourn, M. Mengel, J.-P. Xie, L.-W. Qian, W. Greene, I-T. Yeh, D. Graham, and S.-J. Gao
Kaposi's Sarcoma-Associated Herpesvirus Promotes Angiogenesis by Inducing Angiopoietin-2 Expression via AP-1 and Ets1
J. Virol.,
April 15, 2007;
81(8):
3980 - 3991.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. L. Aranguren, A. Luttun, C. Clavel, C. Moreno, G. Abizanda, M. A. Barajas, B. Pelacho, M. Uriz, M. Arana, A. Echavarri, et al.
In vitro and in vivo arterial differentiation of human multipotent adult progenitor cells
Blood,
March 15, 2007;
109(6):
2634 - 2642.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Hainaud, J.-O. Contreres, A. Villemain, L.-X. Liu, J. Plouet, G. Tobelem, and E. Dupuy
The Role of the Vascular Endothelial Growth Factor-Delta-like 4 Ligand/Notch4-Ephrin B2 Cascade in Tumor Vessel Remodeling and Endothelial Cell Functions.
Cancer Res.,
September 1, 2006;
66(17):
8501 - 8510.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. R. Kumar, J. Singh, G. Xia, V. Krasnoperov, L. Hassanieh, E. J. Ley, J. Scehnet, N. G. Kumar, D. Hawes, M. F. Press, et al.
Receptor Tyrosine Kinase EphB4 Is a Survival Factor in Breast Cancer
Am. J. Pathol.,
July 1, 2006;
169(1):
279 - 293.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Xia, S. R. Kumar, R. Masood, M. Koss, C. Templeman, D. Quinn, S. Zhu, R. Reddy, V. Krasnoperov, and P. S. Gill
Up-Regulation of EphB4 in Mesothelioma and Its Biological Significance
Clin. Cancer Res.,
June 15, 2005;
11(12):
4305 - 4315.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|